Peters C, Bruno A, Rizzari C, Brescianini A, von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F. Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen. haematol [Internet]. 2020Sep.10 [cited 2024Sep.30];. Available from: https://haematologica.org/article/view/haematol.2024.285837